November 3, 2025
Authored and Edited by Wyatt L. Bazrod; Erik R. Puknys; Xu Wang*
In Inland Diamond Products Co. v. Cherry Optical Inc., No. 2024-1106 (Fed. Cir. Oct. 15, 2025), the Federal Circuit determined the district court’s grant of summary judgment based on issue preclusion was improper, vacating the decision and remanding the case.
In 2019, the PTAB determined certain claims of Inland Diamond Products’ patents were unpatentable in an IPR. This determination was never appealed to the Federal Circuit. Inland subsequently filed suit against Cherry Optical and asserted claims, all of which depend from claims the Board determined were unpatentable. On summary judgment, the district court ruled issue preclusion applied to limitations previously found unpatentable, and considered only the remaining limitations before ruling the asserted claims were invalid as obvious.
On appeal, the Federal Circuit reversed and remanded, reaffirming the principle that issue preclusion may not apply to issues raised in a subsequent proceeding that applies a different legal standard from the original proceeding. In the IPR context, because the Board’s findings were reached under a lower standard of proof (i.e., preponderance of the evidence), the Federal Circuit held that there could be no issue-preclusive effect in district court invalidity proceedings, where facts must be proven under a higher standard of proof (i.e., clear and convincing evidence). The Court clarified that the district court also erred in reasoning that Inland could defend the asserted claims only because they had been adjudicated as not unpatentable in the IPR. The Court explained that issue preclusion does not attach where the claims were never determined invalid through any Federal Circuit appeal.
*Xu Wang is a Law Clerk at Finnegan.
Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.